The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback